phenol has been researched along with Athletic Injuries in 1 studies
Athletic Injuries: Injuries incurred during participation in competitive or non-competitive sports.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fullerton, BD | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Rotator Cuff Tendinopathy: A Randomized and Blinded Comparison of Superficial and Deep Injection Methods[NCT01402011] | 77 participants (Actual) | Interventional | 2010-11-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Participants were asked about pain at rest, at work, doing sports. The maximum pain reported on a scale ranging from 0 (no pain at all) to 10 (extreme pain) was recorded for each participant. Maximum of pain scores rest, work, sport recorded. Calculated as pain at baseline - pain at 9 months. (NCT01402011)
Timeframe: baseline and 9 months
Intervention | units on a scale (Mean) |
---|---|
25% Dextrose in Ligaments and Tendons | 2.9 |
.1% Lidocaine in Ligaments and Tendons | 1.8 |
.1% Lidocaine Subcutaneous | 1.3 |
Subject marks his pain level at rest, at work, doing sports on a 10 cm scale. Maximum of pain scores rest, work, sport recorded. Calculated as pain at baseline - pain at 3 months. VAS scale is from 0 = no pain to 10 = maximum pain (NCT01402011)
Timeframe: baseline and three months
Intervention | units on a scale (Mean) |
---|---|
25% Dextrose in Ligaments and Tendons | 3.0 |
.1% Lidocaine in Ligaments and Tendons | 2.7 |
.1% Lidocaine Subcutaneous | 2.7 |
Phone call asking how satisfied were they with their treatment 10 = extremely satisfied, 0 = extremely dissatisfied ) (NCT01402011)
Timeframe: Nine months after first injection treatment appointment
Intervention | units on a scale (Mean) |
---|---|
25% Dextrose in Ligaments and Tendons | 6.7 |
.1% Lidocaine in Ligaments and Tendons | 4.7 |
.1% Lidocaine Subcutaneous | 3.9 |
Subject marks his pain level at rest, at work, doing sports on a 10 cm scale. The maximum pain level among the 3 different activities was recorded. (NCT01402011)
Timeframe: 20 minutes before first injection on first day of patient visit
Intervention | units on a scale (Mean) |
---|---|
25% Dextrose in Shoulder Entheses | 7.3 |
.1% Lidocaine in Shoulder Entheses | 6.9 |
.1% Lidocaine Subcu. Above Shouldr Enth. | 6.9 |
http://www.dash.iwh.on.ca/assets/images/pdfs/DASH_quest06.pdf 30 questions assessing ability to use shoulder in everyday activities, each question scored 1 to 5, where one is normal, no problem and five is unable to perform. No data was collected at 9 months. The score ranges from 30 to 150. Higher scores represent worse outcomes. (NCT01402011)
Timeframe: 20 minutes before the first injection and at 3 months
Intervention | units on a scale (Mean) | |
---|---|---|
Baseline | 3 months | |
.1% Lidocaine in Ligaments and Tendons | 71.3 | 54.7 |
.1% Lidocaine Subcutaneous | 69.6 | 61 |
25% Dextrose in Ligaments and Tendons | 72.4 | 61.3 |
From Steven W. Brose, DO, Michael L. Boninger, MD, Bradley Fullerton, MD, Thane McCann, MD, From: Jennifer L. Collinger, BSE, Bradley G. Impink, BSE, Trevor A. Dyson-Hudson, MD Shoulder ultrasound abnormalities, physical examination findings, and pain in manual wheelchair users with spinal cord injury. Arch Phys Med Rehabil 2008 Nov; 89:2086-93, appendix 1 12 parameters of shoulder examination: Biceps tendon/bicipital groove tenderness, Supraspinatus tendon/greater tuberosity tenderness Acromioclavicular joint tenderness Resisted external rotation. Resisted internal rotation. Supraspinatus test. Painful Arc Test. Neer impingement sign. Hawkins-Kennedy impingement sign. O'Brien Active Compression Test for AC Joint Pathology O'Brien Active Compression Test for Labral Pathology impingement sign. each test scored 0 = no pain, 1 = tenderness, 2 = pain. All 12 scores added. Range 0-24. Higher scores = more pathology (NCT01402011)
Timeframe: 20 minutes before first injection on first day of patient visit and at 3 months
Intervention | units on a scale (Mean) | |
---|---|---|
Baseline | 3 months | |
.1% Lidocaine in Ligaments and Tendons | 13.1 | 10.7 |
.1% Lidocaine Subcutaneous | 13 | 12.9 |
25% Dextrose in Ligaments and Tendons | 13.2 | 11.4 |
"From Brose et al. shoulder ultrasound abnormalities, physical examination findings, and pain in manual wheelchair users with spinal cord injury Arch Phys Med Rehabil 2008 Nov, 89: 2086-93 appendix 2. rates biceps tendinopathy (0-6), supraspinatus tendinopathy (0-5), greater tuberosity the cortical surface (0-3), dynamics supraspinatus impingement (0-3), dynamic subscapularis/ biceps/ coracoid impingement (0-3). The total score ranged from 0 to 20 with higher scores indicating a worse outcome. The change was calculated by taking the final score - the baseline score." (NCT01402011)
Timeframe: 20 minutes before first injection on first day of patient visit and at on average 9.4 months
Intervention | units on a scale (Mean) | |
---|---|---|
Baseline | change at 9.4 +/- 2.2 months | |
.1% Lidocaine in Ligaments and Tendons | 4.3 | -0.6 |
.1% Lidocaine Subcutaneous | 4.3 | -0.6 |
25% Dextrose in Ligaments and Tendons | 4.0 | -0.3 |
1 other study available for phenol and Athletic Injuries
Article | Year |
---|---|
High-resolution ultrasound and magnetic resonance imaging to document tissue repair after prolotherapy: a report of 3 cases.
Topics: Adolescent; Adult; Anesthetics, Local; Ankle Injuries; Athletic Injuries; Chronic Disease; Female; G | 2008 |